.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized trials of preimplantation genetic testing for aneuploidy (PGT-A) show a nuanced picture. In some IVF populations, selecting euploid embryos can reduce the number of embryos transferred and may improve implantation efficiency, but randomized evidence has not established a universal increase in cumulative live-birth rate for all patients. For reproductive specialists, the value of PGT-A depends on maternal age, embryo yield, laboratory quality and the goal of treatment. PGT-A is a screening test applied to embryo biopsy material and is not a guarantee of a chromosomally normal fetus. Genetic counseling remains important, especially when mosaic or inconclusive results occur. The clinical discussion should therefore focus on the individual probability of obtaining transferable embryos, time to pregnancy and cumulative outcomes rather than assuming that more genetic information always produces a higher live-birth rate.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized trials of preimplantation genetic testing for aneuploidy (PGT-A) show a nuanced picture. In some IVF populations, selecting euploid embryos can reduce the number of embryos transferred and may improve implantation efficiency, but randomized evidence has not established a universal increase in cumulative live-birth rate for all patients. For reproductive specialists, the value of PGT-A depends on maternal age, embryo yield, laboratory quality and the goal of treatment. PGT-A is a screening test applied to embryo biopsy material and is not a guarantee of a chromosomally normal fetus. Genetic counseling remains important, especially when mosaic or inconclusive results occur. The clinical discussion should therefore focus on the individual probability of obtaining transferable embryos, time to pregnancy and cumulative outcomes rather than assuming that more genetic information always produces a higher live-birth rate.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
